Immunotheraphy in Allergic Diseases

Title:Immunotheraphy in Allergic Diseases

Volume: 24 Issue: 11

Author(s): Albert Roger, Maria Basagana, Aina Teniente-Serra, Nathalie Depreux, Yanina Jurgens, Clara Padro, Sira Miquel, Carolina Elduque and Eva M. Martinez-Caceres*

Affiliation:

• Division of Immunology, Germans Trias i Pujol University Hospital and Research Institute, Campus Can Ruti, 08916 Badalona,Spain

Keywords: Immunotherapy, allergy, tolerance, antigens, adjuvants, IgE.

Abstract: The prevalence of allergic diseases is increasing worldwide. It is estimated that more than 30% of the world population is now affected by one or more allergic conditions and a high proportion of this increase is in young people. The diagnosis of allergy is dependent on a history of symptoms on exposure to an allergen together with the detection of allergen-specific IgE. Accurate diagnosis of allergies opens up therapeutic options. Allergen specific immunotherapy is the only successful disease-modifying therapy for IgE-mediated allergic diseases. New therapeutic strategies have been developed or are currently under clinical trials. Besides new routes of administration, new types of allergens are being developed. The use of adjuvants may amplify the immune response towards tolerance to the antigens. In this review, we analyze different antigen-specific immunotherapies according to administration route, type of antigens and adjuvants, and we address the special case of food allergy.

Cite this article as:

Roger Albert , Basagana Maria , Teniente-Serra Aina , Depreux Nathalie , Jurgens Yanina , Padro Clara , Miquel Sira , Elduque Carolina and Martinez-Caceres M. Eva *, Immunotheraphy in Allergic Diseases, Current Pharmaceutical Design 2018; 24 (11) . https://dx.doi.org/10.2174/1381612824666180116094048